BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Drug Approval

Takeda Wins U.S. FDA Approval to Expand VONVENDI Use in Adults and Children with Von Willebrand Disease

Approval Expands Use of VONVENDI to Include Routine Prophylaxis to Reduce the Frequency of Bleeding Episodes in Adults with Type 1 and 2 Von Willebrand D...

September 08, 2025 | Regulatory

Stallergenes Greer and Nuance Pharma Enter Exclusive Partnership to Develop and Commercialise Actair® in China

Stallergenes Greer, a global leader in allergy therapeutics, and Nuance Pharma, an innovation-focused biopharmaceutical company based in China, announced t...

September 05, 2025 | News

China’s Bon Natural Life Unveils Tea-Derived Compounds for Weight Management Through AI-Powered Drug Discovery

Bon Natural Life Limited , a leading bio-ingredient solution provider in the natural, health and personal care industry, announced a groundbreaking identif...

September 03, 2025 | News

Daiichi Sankyo Europe Initiates Development of Oral Triple Combination Tablets to Enhance LDL-C Management

Daiichi Sankyo Europe announced the initiation of the development of new oral triple combination tablets in Europe containing bempedoic acid, ezetimibe, an...

September 02, 2025 | News

FDA Approves Subcutaneous Leqembi Iqlik, Ushering in a New Era of Alzheimer’s Treatment

U.S. Food and Drug Administration (FDA) announced its approval of a subcutaneous formulation of Leqembi (lecanemab), branded as Leqembi Iql...

September 01, 2025 | News

China’s D3 Bio Secures FDA Breakthrough and Orphan Drug Designations for KRAS G12C Inhibitor D3S-001

Breakthrough Therapy Designation was granted for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cel...

August 29, 2025 | News

MS Pharma Inaugurates Middle East’s First SFDA-Approved Biologics Manufacturing Facility In Saudi Arabia

MS Pharma inaugurates Middle East's first biologics manufacturing facility in Saudi Arabia, SFDA-approved and built to meet EMA and F...

August 28, 2025 | News

Abbott Secures Thailand Approval For Denosumab Biosimilar Expanding Access To Osteoporosis Treatment

Abbott denosumab biosimilar has received regulatory approval in Thailand, expanding access to advanced therapies for osteoporosis and cancer-related bone l...

August 27, 2025 | News

BioDlink Secures Indonesian Approval for Bevacizumab, Accelerating ASEAN and Global Expansion

BioDlink announced that its Bevacizumab Injection has obtained marketing authorization from Indonesia's National Agency of Drug and Food Con...

August 22, 2025 | News

Everest Medicines’ Etrasimod (VELSIPITY®) Receives Strong Recommendation in Updated ACG Clinical Guideline for Ulcerative Colitis

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, a...

August 18, 2025 | News

Jiangsu Vcare and Huadong Medicine Form Exclusive Partnership for Commercialization of VC005 Tablets in China

Jiangsu Vcare Pharmatech Co., Ltd. (Jiangsu Vcare) announced that it has entered into an exclusive strategic partnership with Huadong Medicine (H...

August 18, 2025 | News

Shilpa Medicare Becomes World’s First to Gain Approval for NorUDCA, Pioneering Treatment for Over a Billion NAFLD Patients

NAFLD affects 1 in 4 people globally (1.2 billion), with 188 million patients in India—most undiagnosed until irreversible damage...

August 14, 2025 | News

Everest Medicines Secures Full Taiwan Approval for NEFECON® in IgA Nephropathy

Everest Medicines (HKEX 1952.HK) recently announced the Taiwan Food and Drug Administration (TFDA) has approved the supplementary application for NEFECON(R...

August 12, 2025 | News

Bracco Imaging’s SonoVue® Gains NMPA Approval for HyCoSy Use in Infertility Diagnosis in China

Bracco Imaging, a global leader in diagnostic imaging,announced that its ultrasound contrast agent SonoVue® has been approved by the China's&...

August 06, 2025 | News

Stay Connected